Literature DB >> 22294402

Monocrotaline-induced pulmonary hypertension in Wistar rats.

Markus Rey1, Patrick Hess, Martine Clozel.   

Abstract

Pulmonary arterial hypertension (PAH) is a debilitating and often fatal disease characterized by a progressive increase in pulmonary vascular resistance that leads to right ventricular failure. Described in this unit is an in vivo model of monocrotaline-induced pulmonary hypertension in rats that can be used to assess the effects of antihypertensive agents on pulmonary artery pressure and right ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22294402     DOI: 10.1002/0471141755.ph0556s46

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  1 in total

1.  Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.

Authors:  Rong Zhu; Liqing Bi; Hui Kong; Weiping Xie; Yongqing Hong; Hong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.